Radioactive drug trial offers new hope for Tough-to-Treat breast cancer
NCT ID NCT06590857
Summary
This early-stage trial is testing an experimental radioactive drug called RYZ101 for people with advanced ER+ breast cancer that has spread and stopped responding to standard treatments. The study aims to find a safe dose and see if the drug can shrink tumors in patients whose cancer cells show a specific marker on scans. It is for patients who have already tried other advanced therapies like antibody-drug conjugates or chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Facility
Phoenix, Arizona, 85054, United States
-
Research Facility
Irvine, California, 92618, United States
-
Research Facility
San Diego, California, 92093, United States
-
Research Facility
Santa Monica, California, 90404, United States
-
Research Facility
Longmont, Colorado, 80504, United States
-
Research Facility
Jacksonville, Florida, 32224, United States
-
Research Facility
Atlanta, Georgia, 30322, United States
-
Research Facility
Indianapolis, Indiana, 46202, United States
-
Research Facility
Boston, Massachusetts, 02215, United States
-
Research Facility
Detroit, Michigan, 48202, United States
-
Research Facility
Rochester, Minnesota, 55905, United States
-
Research Facility
St Louis, Missouri, 63130, United States
-
Research Facility
Omaha, Nebraska, 68124, United States
-
Research Facility
Albuquerque, New Mexico, 87109, United States
-
Research Facility
Buffalo, New York, 14203, United States
-
Research Facility
New York, New York, 10016, United States
-
Research Facility
New York, New York, 10021, United States
-
Research Facility
Cleveland, Ohio, 44195, United States
-
Research Facility
Philadelphia, Pennsylvania, 19104, United States
-
Research Facility
Pittsburgh, Pennsylvania, 15213, United States
-
Research Facility
Dallas, Texas, 75246, United States
-
Research Facility
Houston, Texas, 77024, United States
-
Research Facility
Salt Lake City, Utah, 84132, United States
-
Research Facility
Norfolk, Virginia, 23502, United States
-
Research Facility
Seattle, Washington, 98109, United States
-
Research Facility
Victoria, British Columbia, V8R 6V5, Canada
-
Research Facility
Toronto, Ontario, M4N 3M5, Canada
-
Research Facility
Toronto, Ontario, M5G 2M9, Canada
-
Research Facility
Québec, Quebec, G1S 4L8, Canada
-
Research Facility
Seoul, Seoul, 03080, South Korea
-
Research Facility
Seoul, Seoul, 05505, South Korea
Conditions
Explore the condition pages connected to this study.